FKBP5 Induces Senescence in BMSCs and Inhibits Osteogenic Differentiation Through the Canonical WNT/β‐Catenin Signalling Pathway in Senile Osteoporosis
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70552 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Bin Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Osteoporosis, Osteogenesis, Tacrolimus Binding Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Doctoral Program of Entrepreneurship and Innovation in Jiangsu Province, Jiangsu Province Postdoctoral Science Foundation.
Abstract (Originalsprache)
Senile osteoporosis and its associated fractures significantly contribute to increased morbidity, mortality, and healthcare costs among older adults. Further research is needed to elucidate the molecular mechanisms underlying senile osteoporosis. This study found that FKBP5 expression in bone marrow mesenchymal stem cells (BMSCs) increases with age and is inversely correlated with patients' bone mineral density and CT values. Functional analyses revealed that FKBP5 plays a crucial regulatory role in BMSC osteogenic differentiation, acting through the canonical WNT/β‐catenin signalling pathway. FKBP5 binds to β‐catenin, promoting its ubiquitination and degradation. Importantly, administration of SAFit2, a selective FKBP5 inhibitor, enhanced bone mineral density in an animal model of senile osteoporosis. These findings suggest that FKBP5 may represent a novel therapeutic target and provide new insights into the treatment of senile osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
- Institute of Microsurgery on Extremities, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
ORCID-Profile: Bin Zhu
Förderung
- National Natural Science Foundation of China
- Doctoral Program of Entrepreneurship and Innovation in Jiangsu Province
- Jiangsu Province Postdoctoral Science Foundation
- China Postdoctoral Science Foundation
Zitieren
APA
Zhu, B., Cai, B., Xue, K., Zhou, S., Yin, G., & Fang, J. (2025). FKBP5 Induces Senescence in BMSCs and Inhibits Osteogenic Differentiation Through the Canonical WNT/β‐Catenin Signalling Pathway in Senile Osteoporosis. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70552
Vancouver
Zhu B, Cai B, Xue K, Zhou S, Yin G, Fang J. FKBP5 Induces Senescence in BMSCs and Inhibits Osteogenic Differentiation Through the Canonical WNT/β‐Catenin Signalling Pathway in Senile Osteoporosis. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70552
BibTeX
@article{Zhu2025,
author = {Zhu, Bin and Cai, Bowen and Xue, Kaixiao and Zhou, Shumin and Yin, Guoyong and Fang, Jiahu},
title = {FKBP5 Induces Senescence in BMSCs and Inhibits Osteogenic Differentiation Through the Canonical WNT/β‐Catenin Signalling Pathway in Senile Osteoporosis},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70552}
}
EUVIMED